Merrill Corp W/ - Fa (COLL)

In this article, we will take a look at some of the small-cap drug manufacturing stocks that are highly favored by hedge funds.

Third Avenue Management, a New York City-based investment firm, published its fourth-quarter 2025 investor letter for the “Third Avenue Small-Cap Value Fund.

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2025 Earnings Call Transcript February 26, 2026Collegium Pharmaceutical, Inc. misses on earnings expectations.

TheFly reported on February 10 that Truist Securities analyst Les Sulewski raised its price target on COLL to $58 from $55 and gave it a Buy rating. The analyst emphasized the robustness of the company...

According to research, the U.S.

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2025 Earnings Call Transcript November 6, 2025Collegium Pharmaceutical, Inc. beats earnings expectations.

 We came across a bullish thesis on Collegium Pharmaceutical, Inc. on The Catholic Capitalist’s Substack by Logan Shearer. In this article, we will summarize the bulls’ thesis on COLL.

Collegium Pharmaceutical, Inc.

According to a recent White House announcement, President Trump wrote letters to 17 major pharmaceutical companies outlining the actions they could take to bring the prices of prescription pharmaceuticals...